Viking Therapeutics, Inc. ($VKTX)
ZANTE GREG โ Chief Financial Officer
Shares
10,300
Price
$34.24
Total Value
$352,634.92
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | ZANTE GREG |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Jan 5, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock, par value $0.00001 per share |
| Direct/Indirect | Direct |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Shares Sold | 10,300 |
| Price per Share | $34.24 |
| Total Value | $352,634.92 |
| Shares Owned After | 191,371 |
| Derivative | No |
| Accession Number | 0001193125-26-003116 |
| Document | View SEC Filing |